Morgan Stanley’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-20,200
| Closed | -$27.9K | – | 8088 |
|
2024
Q3 | $27.9K | Buy |
20,200
+20,199
| +2,019,900% | +$27.9K | ﹤0.01% | 6396 |
|
2024
Q2 | $4 | Hold |
1
| – | – | ﹤0.01% | 7815 |
|
2024
Q1 | $7 | Sell |
1
-40
| -98% | -$280 | ﹤0.01% | 7782 |
|
2023
Q4 | $444 | Buy |
+41
| New | +$444 | ﹤0.01% | 7292 |
|
2023
Q3 | – | Hold |
0
| – | -$12 | – | 7578 |
|
2023
Q2 | – | Hold |
0
| – | -$7 | – | 7598 |
|
2023
Q1 | – | Sell |
-27
| Closed | -$305 | – | 7681 |
|
2022
Q4 | $305 | Buy |
27
+15
| +125% | +$169 | ﹤0.01% | 7605 |
|
2022
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 7873 |
|
2022
Q2 | $1K | Buy |
12
+1
| +9% | +$83 | ﹤0.01% | 7706 |
|
2022
Q1 | $1K | Sell |
11
-73
| -87% | -$6.64K | ﹤0.01% | 7872 |
|
2021
Q4 | $6K | Hold |
84
| – | – | ﹤0.01% | 7611 |
|
2021
Q3 | $10K | Buy |
84
+83
| +8,300% | +$9.88K | ﹤0.01% | 7332 |
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7802 |
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7564 |
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7112 |
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6826 |
|
2020
Q2 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 6722 |
|
2020
Q1 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 6706 |
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6762 |
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6758 |
|
2019
Q2 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 6748 |
|
2019
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 6706 |
|
2018
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 6736 |
|
2018
Q3 | $1K | Sell |
2
-2
| -50% | -$1K | ﹤0.01% | 6652 |
|
2018
Q2 | $9K | Buy |
4
+1
| +33% | +$2.25K | ﹤0.01% | 6333 |
|
2018
Q1 | $7K | Buy |
3
+1
| +50% | +$2.33K | ﹤0.01% | 6342 |
|
2017
Q4 | $10K | Sell |
2
-2
| -50% | -$10K | ﹤0.01% | 6219 |
|
2017
Q3 | $35K | Sell |
4
-26
| -87% | -$228K | ﹤0.01% | 5882 |
|
2017
Q2 | $151K | Buy |
30
+11
| +58% | +$55.4K | ﹤0.01% | 5469 |
|
2017
Q1 | $106K | Sell |
19
-26
| -58% | -$145K | ﹤0.01% | 5578 |
|
2016
Q4 | $300K | Buy |
45
+31
| +221% | +$207K | ﹤0.01% | 5186 |
|
2016
Q3 | $215K | Buy |
14
+1
| +8% | +$15.4K | ﹤0.01% | 4984 |
|
2016
Q2 | $197K | Sell |
13
-4
| -24% | -$60.6K | ﹤0.01% | 4945 |
|
2016
Q1 | $349K | Buy |
17
+3
| +21% | +$61.6K | ﹤0.01% | 4640 |
|
2015
Q4 | $279K | Sell |
14
-21
| -60% | -$419K | ﹤0.01% | 4903 |
|
2015
Q3 | $701K | Buy |
35
+27
| +338% | +$541K | ﹤0.01% | 4381 |
|
2015
Q2 | $194K | Hold |
8
| – | – | ﹤0.01% | 5258 |
|
2015
Q1 | $151K | Buy |
8
+4
| +100% | +$75.5K | ﹤0.01% | 5337 |
|
2014
Q4 | $51K | Hold |
4
| – | – | ﹤0.01% | 5814 |
|
2014
Q3 | $57K | Hold |
4
| – | – | ﹤0.01% | 5687 |
|
2014
Q2 | $55K | Sell |
4
-35
| -90% | -$481K | ﹤0.01% | 5736 |
|
2014
Q1 | $884K | Buy |
39
+36
| +1,200% | +$816K | ﹤0.01% | 4104 |
|
2013
Q4 | $41K | Sell |
3
-2
| -40% | -$27.3K | ﹤0.01% | 5668 |
|
2013
Q3 | $79K | Hold |
5
| – | – | ﹤0.01% | 5140 |
|
2013
Q2 | $81K | Buy |
+5
| New | +$81K | ﹤0.01% | 5121 |
|